← Back to home
Comparison · Analytics

DoseFinding vs r2rtf

A side-by-side editorial comparison of DoseFinding and r2rtf — release velocity, themes, recent moves, and the top alternatives to consider.

DoseFinding vs r2rtf: at a glance

FeatureDoseFindingr2rtf
SectorAnalyticsAnalytics
Velocity score0.00.0
Sparks · 30d00
Top themesdose-response, mcp-mod, clinical-trials, model-averagingclinical-reporting, rtf, internationalization, document-conversion
Last editorial update1h ago1h ago
WebsiteVisit →Visit →

What is DoseFinding?

New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing

DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.

Read the full DoseFinding trajectory →

What is r2rtf?

The clinical-report table engine learned Chinese, then learned to leave RTF entirely

r2rtf builds the RTF tables, listings and figures that go into clinical study reports, and its recent releases have been about widening who and what it can serve rather than changing how tables are composed. The 1.2.0 release added internationalization — a SimSun font path for Chinese characters plus hyphenation control — and 1.3.0 followed with write_docx() and write_html(), turning the LibreOffice conversion the package had documented into exported functions.

Read the full r2rtf trajectory →

DoseFinding vs r2rtf: editorial side-by-side

D
DoseFinding
ANALYTICS
0.0

New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing

◆ Current state

DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.

◆ Where it's heading

The pattern before the handover was maintenance — R-devel compliance, a bug fix, a link. After it, each release carries a named methodological addition with an acknowledged contributor, plus documentation to match: a longitudinal analysis vignette shipped alongside the interim power work. Housekeeping continues underneath, mostly clearing deprecated ggplot2 interfaces, aes_string in one release and qplot in the next.

◆ Prediction

Given the last two releases each added one method with a supporting vignette, expect the next to follow the same shape. Both additions so far extend the package beyond fixed dose-response fitting, so adaptive and interim methodology is the more likely direction.

R
r2rtf
ANALYTICS
0.0

The clinical-report table engine learned Chinese, then learned to leave RTF entirely

◆ Current state

r2rtf builds the RTF tables, listings and figures that go into clinical study reports, and its recent releases have been about widening who and what it can serve rather than changing how tables are composed. The 1.2.0 release added internationalization — a SimSun font path for Chinese characters plus hyphenation control — and 1.3.0 followed with write_docx() and write_html(), turning the LibreOffice conversion the package had documented into exported functions.

◆ Where it's heading

Two threads run through the window. One is output reach: RTF remains the composition target, but the artifacts that come out of it now include DOCX and HTML, and page numbering can be made table-relative across multi-page tables. The other is durability under a moving R and font stack — the ANSI/Unicode converter was rebuilt, the LaTeX mapping table generated from code rather than shipped as sysdata, unlist() usage fixed for R 4.5, and graphics-device leaks that produced stray Rplots.pdf closed off.

◆ Prediction

Having exported DOCX and HTML conversion, the likely next step is filling in what those formats lose relative to RTF — pagination and footnote fidelity are the obvious gaps. The i18n path currently covers Chinese only, so additional font families are the other plausible direction.

Alternatives to DoseFinding and r2rtf

Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either DoseFinding or r2rtf.

See all DoseFinding alternatives → · See all r2rtf alternatives →

Recent activity from DoseFinding and r2rtf

Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.

  1. 7mo agor2rtfDOCX and HTML output become exported functions
  2. 11mo agor2rtfChinese character support arrives via an i18n font path
  3. 1y agoDoseFindingConditional and predictive power for interim analyses
  4. 1y agoDoseFindingModel averaging arrives for dose-response fitting
  5. 1y agor2rtfText colour fixed for figures encoded into RTF
  6. 1y agor2rtfFootnote handling fixed for R 4.5.0
  7. 1y agor2rtfUnicode converter rebuilt and mapping table made inspectable
  8. 1y agoDoseFindingPackage moves to openpharma under new maintainership
  9. 2y agoDoseFindingCompliance update for R-devel
  10. 2y agor2rtfUTF-8 conversion fix and LibreOffice 7.6 support
  11. 3y agoDoseFindingpowMCTBinCount bug fix

Frequently asked questions

What is the difference between DoseFinding and r2rtf?

They serve adjacent needs but don't currently overlap on shipped themes. DoseFinding and r2rtf are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.

Is DoseFinding better than r2rtf?

Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. DoseFinding and r2rtf are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.

What are the best alternatives to DoseFinding?

Top DoseFinding alternatives in Analytics are ranked by recent ship velocity. Browse the "DoseFinding alternatives" section above for the current picks, or visit /alternatives/dosefinding for the full list with editorial commentary on each.

What are the best alternatives to r2rtf?

Top r2rtf alternatives in Analytics are ranked by recent ship velocity. Browse the "r2rtf alternatives" section above for the current picks, or visit /alternatives/r2rtf for the full list with editorial commentary on each.